BioPharmaceuticals

改变数十亿慢性病患者的护理方式

Home / Our therapy areas / BioPharmaceuticals

Through our work in BioPharmaceuticals, we want to transform healthcare, 改善数十亿人的生活，解决人类面临的一些最大的医疗保健挑战. 在治疗慢性病患者方面，仍有巨大的需求未得到满足. 澳门葡京赌博游戏的目标是阻止这些经常退化的进步, debilitating and life-threatening conditions. So many more people can live better, healthier lives.

Introduction

澳门葡京赌博游戏部负责心血管、肾脏等关键治疗领域 & Metabolism and Respiratory & Immunology and Vaccines & Immune Therapies.

Our BioPharmaceuticals R&D和业务部门在澳门葡京赌博游戏的方法上是统一的，为最常见的慢性病患者提供改变生活的药物.

澳门葡京赌博游戏将通过澳门葡京赌博游戏才华横溢的团队和合作伙伴，利用科学技术，实现澳门葡京赌博游戏改变医疗保健的雄心, medical and commercial innovation.

了解澳门葡京赌博游戏的联合方针对使人们过上更好、更健康生活的重要性.

BioPharmaceuticals Therapy Areas

Cardiovascular, Renal and Metabolism

澳门葡京赌博游戏的目标是挽救患有心血管疾病的人的生命, heart failure, chronic kidney disease and diabetes, by advancing Cardiovascular, 肾脏和代谢解决方案，并解决这些不同但相互关联的疾病领域之间的共同风险因素.

Respiratory & Immunology

澳门葡京赌博游戏正在进入一个具有前所未有潜力的时代，在哮喘领域实现科学突破, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

Vaccines and Immune Therapies

开发和提供变革性疫苗和抗体，为数百万人提供持久免疫, where the burden of disease is greatest.

Neuroscience

We are selectively active in neuroscience, 遵循机会驱动的方法，并与合作伙伴合作，为患者带来影响.

BioPharmaceuticals R&D

澳门葡京赌博游戏的科学正在改变慢性病治疗的轨迹.

Transforming our science

澳门葡京赌博游戏希望对疾病产生最大最快的影响, 澳门葡京赌博游戏正在四个领域进行投资——加强澳门葡京赌博游戏对疾病生物学的理解, creating the next generation of therapeutics, better predicting clinical success, 并且在诊所和其他领域开创了参与的新方法.

Read about our approach to R&D

What science can do

To unlock the power of what science can do, 澳门葡京赌博游戏总是在寻找新的知识和下一个突破. 澳门葡京赌博游戏的文化是一种独特的融合，充满了充满好奇的人, harnessing data and technology, working seamlessly and inclusively, and always learning from patients.

Read our latest science stories

BioPharmaceuticals Business Unit

Our commercial teams are transforming how we bring products to market; engage with patients, healthcare providers and health systems; and deliver healthcare solutions that support them.

Transforming patient experiences

澳门葡京赌博游戏正在利用数据分析来改变患者的体验, omnichannel approaches, 进入市场模式，共同帮助制定商业战略, improve patient and healthcare professional experiences, 并配合当地医疗生态系统和渠道偏好的演变.

Unlocking the potential of our medicines

提供高价值的市场准入解决方案释放了澳门葡京赌博游戏改变患者生活的药物的潜力. 澳门葡京赌博游戏还将科学与现实世界的实践相结合，以产生和传播令人信服的医学证据，以发展治疗前景，改善对患者的护理.

Our people

澳门葡京赌博游戏使最优秀的人才能够帮助塑造医疗保健的未来.

澳门葡京赌博游戏将继续创造一种吸引和留住最优秀人才的商业和文化, most talented and dedicated people, 给他们提供资源和支持，以突破界限，超越平凡，帮助改善数十亿人的生活.

Maria Belvisi

高级副总裁兼研究和早期开发主管，呼吸 & Immunology, BioPharmaceuticals R&D
Elisabeth Björk

高级副总裁，后期开发，心血管，肾脏和代谢(CVRM)，澳门葡京赌博游戏公司&D
Mina Maker

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit

Join us

如果你相信科学的力量，并希望帮助澳门葡京赌博游戏改善数十亿人的生活，解决人类面临的一些最大的医疗挑战, join us.

Visit our careers website

The future of healthcare

Collaborating for success

We know that however innovative our science is, however effective our medicines and delivery are, to achieve all we want to achieve we cannot do it alone. From drug discovery collaborations to commercial partnerships, 澳门葡京赌博游戏的目标是在信任和透明的基础上建立互利的伙伴关系.

Partner with us

Veeva ID: Z4-52142
Date of preparation: February 2023